TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm controlPatrick Lugenbiel, Dierk Thomas, Derk Frank et al.|Basic Research in Cardiology|2016Cited by 48
Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular systemFelix Wiedmann, Dierk Thomas, Patrick A. Schweizer et al.|Clinical Science|2016Cited by 47
Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial CardiomyocytesPatrick Lugenbiel, Dierk Thomas, Ann‐Kathrin Rahm et al.|Cellular Physiology and Biochemistry|2018Cited by 21